[Skip to Content]
[Skip to Content Landing]
Other Articles
November 4, 1950


Author Affiliations

New Orleans; Houston, Texas; New Orleans

From the Department of Surgery, Tulane University School of Medicine, and the Ochsner Clinic, New Orleans (Drs. Ochsner and DeCamp) and from the Department of Surgery, College of Medicine, Baylor University, Houston, Texas (Dr. DeBakey).

JAMA. 1950;144(10):831-834. doi:10.1001/jama.1950.02920100019006

Intravenous clotting is an extremely undesirable complication because of its serious potentialities, which vary from sudden death to the development of persistent disabling sequelae. As we have previously emphasized, it is desirable to differentiate between two types of venous thrombosis, thrombophlebitis and phlebothrombosis. Thrombophlebitis, or phlegmasia alba dolens, usually causes severe symptoms which consist of fever, pain and swelling of the involved extremity. The clot in thrombophlebitis, which is secondary to inflammatory changes in the intima, is firmly attached to the vein wall and except in suppurative thrombophlebitis is not likely to become detached with the production of embolism. Because of this, fatalities are rare; but the persistence of disabling sequelae is the rule unless adequate therapy is instituted during the acute phase of the condition. On the other hand, in phlebothrombosis the intravenous clot is a coagulation thrombus resulting from two factors, of which one is predisposing and the

First Page Preview View Large
First page PDF preview
First page PDF preview